Skip to main content
. 2026 Jan 20;18(1):8. doi: 10.21037/jtd-2025-1861

Figure 1.

Figure 1

Flowchart of the patient selection process for this study. AP, pemetrexed plus platinum; NSCLC, non-small cell lung cancer.